A double-blind comparative study of ketanserin with atenolol in essential hypertension

R. Antonicelli, A. Andreoni, G. Saccomanno, C. Gambini, E. Paciaroni

Research output: Contribution to journalArticle

Abstract

Sixty patients, with mild to moderate essential hypertension, were considered for a double-blind trial comparing the effects of ketanserin and atenolol. After 2 weeks of placebo, a group of 30 patients was given ketanserin 20 mg twice daily 15 days and 40 mg twice daily for the subsequent 45 days, while the second group (30 patients) was given atenolol for 60 days at the dose of 100 mg once daily. Blood pressure and pulse rate in the supine and standing positions were evaluated every 15 days. After the beginning of treatment with ketanserin, there was a gradual but highly significant decrease of the diastolic and systolic blood pressure values. No important side-effects or significant alterations in the biochemical parameters considered were observed during treatment with ketanserin.

Original languageEnglish
Pages (from-to)577-581
Number of pages5
JournalDrugs under Experimental and Clinical Research
Volume15
Issue number11-12
Publication statusPublished - 1989

Fingerprint

Ketanserin
Atenolol
Double-Blind Method
Blood Pressure
Supine Position
Posture
Heart Rate
Placebos
Essential Hypertension
Therapeutics

ASJC Scopus subject areas

  • Molecular Medicine
  • Pharmacology (medical)
  • Drug Discovery
  • Pharmacology

Cite this

A double-blind comparative study of ketanserin with atenolol in essential hypertension. / Antonicelli, R.; Andreoni, A.; Saccomanno, G.; Gambini, C.; Paciaroni, E.

In: Drugs under Experimental and Clinical Research, Vol. 15, No. 11-12, 1989, p. 577-581.

Research output: Contribution to journalArticle

Antonicelli, R, Andreoni, A, Saccomanno, G, Gambini, C & Paciaroni, E 1989, 'A double-blind comparative study of ketanserin with atenolol in essential hypertension', Drugs under Experimental and Clinical Research, vol. 15, no. 11-12, pp. 577-581.
Antonicelli, R. ; Andreoni, A. ; Saccomanno, G. ; Gambini, C. ; Paciaroni, E. / A double-blind comparative study of ketanserin with atenolol in essential hypertension. In: Drugs under Experimental and Clinical Research. 1989 ; Vol. 15, No. 11-12. pp. 577-581.
@article{e5a76800714b4cbebbf619d7b9d00287,
title = "A double-blind comparative study of ketanserin with atenolol in essential hypertension",
abstract = "Sixty patients, with mild to moderate essential hypertension, were considered for a double-blind trial comparing the effects of ketanserin and atenolol. After 2 weeks of placebo, a group of 30 patients was given ketanserin 20 mg twice daily 15 days and 40 mg twice daily for the subsequent 45 days, while the second group (30 patients) was given atenolol for 60 days at the dose of 100 mg once daily. Blood pressure and pulse rate in the supine and standing positions were evaluated every 15 days. After the beginning of treatment with ketanserin, there was a gradual but highly significant decrease of the diastolic and systolic blood pressure values. No important side-effects or significant alterations in the biochemical parameters considered were observed during treatment with ketanserin.",
author = "R. Antonicelli and A. Andreoni and G. Saccomanno and C. Gambini and E. Paciaroni",
year = "1989",
language = "English",
volume = "15",
pages = "577--581",
journal = "Drugs under Experimental and Clinical Research",
issn = "0378-6501",
publisher = "Bioscience Ediprint Inc.",
number = "11-12",

}

TY - JOUR

T1 - A double-blind comparative study of ketanserin with atenolol in essential hypertension

AU - Antonicelli, R.

AU - Andreoni, A.

AU - Saccomanno, G.

AU - Gambini, C.

AU - Paciaroni, E.

PY - 1989

Y1 - 1989

N2 - Sixty patients, with mild to moderate essential hypertension, were considered for a double-blind trial comparing the effects of ketanserin and atenolol. After 2 weeks of placebo, a group of 30 patients was given ketanserin 20 mg twice daily 15 days and 40 mg twice daily for the subsequent 45 days, while the second group (30 patients) was given atenolol for 60 days at the dose of 100 mg once daily. Blood pressure and pulse rate in the supine and standing positions were evaluated every 15 days. After the beginning of treatment with ketanserin, there was a gradual but highly significant decrease of the diastolic and systolic blood pressure values. No important side-effects or significant alterations in the biochemical parameters considered were observed during treatment with ketanserin.

AB - Sixty patients, with mild to moderate essential hypertension, were considered for a double-blind trial comparing the effects of ketanserin and atenolol. After 2 weeks of placebo, a group of 30 patients was given ketanserin 20 mg twice daily 15 days and 40 mg twice daily for the subsequent 45 days, while the second group (30 patients) was given atenolol for 60 days at the dose of 100 mg once daily. Blood pressure and pulse rate in the supine and standing positions were evaluated every 15 days. After the beginning of treatment with ketanserin, there was a gradual but highly significant decrease of the diastolic and systolic blood pressure values. No important side-effects or significant alterations in the biochemical parameters considered were observed during treatment with ketanserin.

UR - http://www.scopus.com/inward/record.url?scp=0024892597&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024892597&partnerID=8YFLogxK

M3 - Article

C2 - 2700320

AN - SCOPUS:0024892597

VL - 15

SP - 577

EP - 581

JO - Drugs under Experimental and Clinical Research

JF - Drugs under Experimental and Clinical Research

SN - 0378-6501

IS - 11-12

ER -